• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TAH
Click for more information
0.00% $2.04

Third Age Health Services Limited Ordinary Shares - Announcements

watchlist Created with Sketch. Add to my watchlist
Healthcare

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
TAH Third Age Health announces on-market share buybackPRICE SENSITIVE download Created with Sketch. 154.14KB
TAH Third Age Health - Interim Dividend Q1 FY25PRICE SENSITIVE download Created with Sketch. 154.93KB
TAH Third Age Health reports record Q1 FY25PRICE SENSITIVE download Created with Sketch. 218.3KB
TAH Third Age Health releases 2024 Annual ReportPRICE SENSITIVE download Created with Sketch. 4.45MB
TAH Third Age Health Releases FY24 Preliminary Unaudited ResultPRICE SENSITIVE download Created with Sketch. 118.88KB
TAH TAH confirms acquisition of 70% of Hub Aged CarePRICE SENSITIVE download Created with Sketch. 140.54KB
TAH TAH Enters Conditional Agreement for Elder Care PracticePRICE SENSITIVE download Created with Sketch. 137.27KB
TAH Third Age Health - Interim Dividend 3QPRICE SENSITIVE download Created with Sketch. 116.44KB
TAH Third Age Health delivers strong Q3PRICE SENSITIVE download Created with Sketch. 247.14KB
TAH Third Age Health - Interim Dividend 2QPRICE SENSITIVE download Created with Sketch. 81.96KB
TAH Third Age Half Year ResultsPRICE SENSITIVE download Created with Sketch. 247.28KB
TAH Third Age Health announces on-market share buyback
19/08/24PRICE SENSITIVE download Created with Sketch. 154.14KB
TAH Third Age Health - Interim Dividend Q1 FY25
26/07/24PRICE SENSITIVE download Created with Sketch. 154.93KB
TAH Third Age Health reports record Q1 FY25
26/07/24PRICE SENSITIVE download Created with Sketch. 218.3KB
TAH Third Age Health releases 2024 Annual Report
27/06/24PRICE SENSITIVE download Created with Sketch. 4.45MB
TAH Third Age Health Releases FY24 Preliminary Unaudited Result
27/05/24PRICE SENSITIVE download Created with Sketch. 118.88KB
TAH TAH confirms acquisition of 70% of Hub Aged Care
25/03/24PRICE SENSITIVE download Created with Sketch. 140.54KB
TAH TAH Enters Conditional Agreement for Elder Care Practice
05/03/24PRICE SENSITIVE download Created with Sketch. 137.27KB
TAH Third Age Health - Interim Dividend 3Q
02/02/24PRICE SENSITIVE download Created with Sketch. 116.44KB
TAH Third Age Health delivers strong Q3
02/02/24PRICE SENSITIVE download Created with Sketch. 247.14KB
TAH Third Age Health - Interim Dividend 2Q
27/10/23PRICE SENSITIVE download Created with Sketch. 81.96KB
TAH Third Age Half Year Results
27/10/23PRICE SENSITIVE download Created with Sketch. 247.28KB
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$2.04 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
$2.04 $2.04 $2.04 $373 183

Buyers (Bids)

No. Vol. Price($)
0 101 $1.95
 

Sellers (Offers)

Price($) Vol. No.
$1.99 20 0
Last trade - 03.59am 02/10/2024 (20 minute delay) ?
TAH (NZSX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.